This large human genetics and biomarker study supports the hypothesis that IL-6 mediated inflammation is implicated in the pathophysiology of T2D but suggests that the impact of this pathway on disease risk is likely to be small. The gene discussed is IL6; the disease is type 2 diabetes mellitus.